(Q45756775)

15 December 2017

title

Characterization of V3 loop-Pseudomonas exotoxin chimeras. Candidate vaccines for human immunodeficiency virus-1. (English)

1 reference

15 December 2017

author name string

FitzGerald DJ

1

1 reference

15 December 2017

Fryling CM

2

1 reference

15 December 2017

McKee ML

3

1 reference

15 December 2017

Vennari JC

4

1 reference

15 December 2017

Wrin T

5

1 reference

15 December 2017

Cromwell ME

6

1 reference

15 December 2017

Daugherty AL

7

1 reference

15 December 2017

Mrsny RJ

8

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 April 1998

1 reference

15 December 2017

Journal of Biological Chemistry

published in

1 reference

15 December 2017

volume

273

1 reference

15 December 2017

issue

16

1 reference

15 December 2017

page(s)

9951-9958

1 reference

15 December 2017

Toward a vaccine for AIDS: the emergence of immunobiology-based vaccine development

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.16.9951

Studies in subjects with long-term nonprogressive human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.16.9951

Protection of MN-rgp120-immunized chimpanzees from heterologous infection with a primary isolate of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.16.9951

Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.16.9951

Recombinant toxins as novel therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.16.9951

Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.16.9951

Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.16.9951

Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.16.9951

Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.16.9951

Induction of humoral and cell-mediated anti-human immunodeficiency virus (HIV) responses in HIV sero-negative volunteers by immunization with recombinant gp160.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.16.9951

Broadly neutralizing monoclonal antibodies to the V3 region of HIV-1 can be elicited by peptide immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.16.9951

Structure of exotoxin A of Pseudomonas aeruginosa at 3.0-Angstrom resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.16.9951

Pseudomonas exotoxin-mediated selection yields cells with altered expression of low-density lipoprotein receptor-related protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.16.9951

Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.16.9951

Functional domains of Pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.16.9951

Use of T7 RNA polymerase to direct expression of cloned genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.16.9951

Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.16.9951

Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.16.9951

A microtiter cell-culture assay for the determination of anti-human immunodeficiency virus neutralizing antibody activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.16.9951

Delivery of antigens to the MHC class I pathway using bacterial toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.16.9951

Targeted delivery of peptide epitopes to class I major histocompatibility molecules by a modified Pseudomonas exotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.16.9951

Substitution of foreign protein sequences into a chimeric toxin composed of transforming growth factor alpha and Pseudomonas exotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.16.9951

Translocation mediated by domain II of Pseudomonas exotoxin A: transport of barnase into the cytosol

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.16.9951

Neutralization of HIV-1 by secretory IgA induced by oral immunization with a new macromolecular multicomponent peptide vaccine candidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.16.9951

An engineered poliovirus chimaera elicits broadly reactive HIV-1 neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.16.9951

Human immunodeficiency virus (HIV) antigens: structure and serology of multivalent human mucin MUC1-HIV V3 chimeric proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.16.9951

Insertion of a HIV-1-neutralizing epitope in a surface-exposed internal region of the cholera toxin B-subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.16.9951

Human immunodeficiency virus-1 principal neutralizing domain peptide-toxin A conjugate vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.16.9951

Neutralization of Divergent HIV-1 Isolates by Conformation-Dependent Human Antibodies to Gp120

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.16.9951

Long-term high-titer neutralizing activity induced by octameric synthetic HIV-1 antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.16.9951

Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.16.9951

An anti-gp41 human monoclonal antibody that enhances HIV-1 infection in the absence of complement

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.16.9951

Immune responses induced by administration of encapsidated poliovirus replicons which express HIV-1 gag and envelope proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.16.9951

Candidate HIV type 1 multideterminant cluster peptide-P18MN vaccine constructs elicit type 1 helper T cells, cytotoxic T cells, and neutralizing antibody, all using the same adjuvant immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.16.9951

HIV-1 recombinant gp160 vaccine induced antibodies in serum and saliva. The NIAID AIDS Vaccine Clinical Trials Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.16.9951

General least-squares smoothing and differentiation by the convolution (Savitzky-Golay) method

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.16.9951

Local and global structural properties of the HIV-MN V3 loop

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.16.9951

Antibody-dependent enhancement of HIV-1 infection in human term syncytiotrophoblast cells cultured in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.16.9951

Antibodies to the putative SIV infection-enhancing domain diminish beneficial effects of an SIV gp160 vaccine in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.16.9951

21 January 2018

Identifiers

DOI

10.1074/JBC.273.16.9951

1 reference

15 December 2017

PubMed ID

9545339

1 reference

15 December 2017